Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 157 citing Gulick: 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. (0.08 sec) 

The cost effectiveness of combination antiretroviral therapy for HIV disease

- yale.edu [PDF] 
KA Freedberg, E Losina, MC Weinstein, AD … - The New England …, 2001 - nejm.highwire.org
Methods We developed a mathematical simulation model of HIV disease, using the CD4 cell
count and HIV RNA level as predictors of the progression of disease. Outcome measures included
life expectancy, life expectancy adjusted for the quality of life, lifetime direct medical costs, ...
Cited by 318 - Related articles - BL Direct - All 12 versions

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

- sanbi.ac.za [PDF] 
GK Robbins, V De Gruttola, RW Shafer, LM … - The New England journal …, 2003 - nejm.org
From Harvard Medical School (GKR, MSH) and the Harvard School of Public Health (VDG,
LMS) — both in Boston; the Stanford University Medical Center, Stanford, Calif. (RWS, TCM);
Social & Sci- entific Systems, Silver Spring, Md. (SWS); the Division of AIDS, National ...
Cited by 250 - Related articles - BL Direct - All 11 versions

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral …

- nejm.org
GD Sanders, AM Bayoumi, V Sundaram, SP … - The New England …, 2005 - cme.nejm.org
Results Given a 1 percent prevalence of unidentified HIV infection, screening increased life expectancy
by 5.48 days, or 4.70 quality-adjusted days, at an estimated cost of $194 per screened
patient, for a cost-effectiveness ratio of $15,078 per quality-adjusted life-year. Screening ...
Cited by 231 - Related articles - Cached - All 17 versions

Genotypic testing for human immunodeficiency virus type 1 drug resistance

- nih.gov
RW Shafer - Clinical Microbiology Reviews, 2002 - cmr.highwire.org
There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to three
mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse transcriptase
(RT) inhibitors, and nonnucleoside RT inhibitors. HIV-1 resistance to these drugs is ...
Cited by 202 - Related articles - BL Direct - All 12 versions

Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost- …

- annals.org [PDF] 
MC Weinstein, SJ Goldie, E Losina, CJ … - Annals of internal …, 2001 - Am Coll Physicians
Background: Genotypic sequencing for drug-resistant strains of HIV can guide the choice of antiretroviral
therapy. Objective: To assess the cost-effectiveness of genotypic resis- tance testing for patients
acquiring drug resistance through failed treatment (secondary resistance) and those ...
Cited by 185 - Related articles - BL Direct - All 8 versions

St John's wort increases expression of P-glycoprotein: implications for drug …


M Hennessy, D Kelleher, JP Spiers, M … - British Journal of …, 2002 - pubmedcentral.nih.gov
St John's Wort (SJW) is widely used in the treatment of depression but concerns have been raised
about its potential to interact with other drugs. Co-administration with SJW has resulted in significant
reductions in trough plasma concentrations of indinavir and cyclosporin [1, 2]. Induction of ...
Cited by 151 - Related articles - BL Direct - All 11 versions

TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active …

- nih.gov
S De Meyer, H Azijn, D Surleraux, D … - Antimicrobial agents …, 2005 - Am Soc Microbiol
The purpose of this study was to characterize the antiviral activity, cytotoxicity, and mechanism
of action of TMC114, a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor
(PI). TMC114 exhibited potent anti-HIV activity with a 50% effective concentration (EC 50 ) ...
Cited by 143 - Related articles - BL Direct - All 13 versions

Twenty years of therapy for HIV-1 infection

- emory.edu [PDF] 
RJ Pomerantz, DL Horn - Nature medicine, 2003 - medscape.com
In the 20 years since the isolation of HIV-1, modern drug discovery and development have transformed
HIV-1 disease into a treatable, chronic infectious disease ( Table 1 ), although issues of resistance
to current therapy and viral reservoirs remain. The speed of the US Food and Drug ...
Cited by 134 - Related articles - BL Direct - All 9 versions

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of …


PW Hunt, SG Deeks, B Rodriguez, H Valdez, SB Shade … - Aids, 2003 - journals.lww.com
From the a Positive Health Program, San Francisco General Hospital, University of
California, the b Division of General Internal Medicine, Veterans Affairs Medical Center, San
Francisco, California, the c Center for AIDS Research, Case Western Reserve University, ...
Cited by 115 - Related articles - BL Direct - All 6 versions

Long-term clinical outcome of human immunodeficiency virus-infected patients with …


C Piketty, L Weiss, F Thomas, AS Mohamed, L … - The Journal of …, 2001 - UChicago Press
Featured in Grist "Another symptom of swine flu: instant amnesia" May 11, 2009 Swine Influenza
Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke Read the veterinary literature on swine flu and you get a ...
Cited by 100 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google